(Q36492745)

14 August 2017

1 reference

title

Control of Taenia solium cysticercosis/taeniosis (English)

1 reference

14 August 2017

0 references

0 references

2

Dirk Engels

1 reference

14 August 2017

Arve Lee Willingham

1

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

Advances in Parasitology

1 reference

14 August 2017

61

1 reference

14 August 2017

509-566

1 reference

Immunodiagnosis of taeniasis by coproantigen detection.

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Dipstick dot ELISA for the detection of Taenia coproantigens in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiology of intestinal taeniasis in four, rural, Guatemalan communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

First case of neurocysticercosis in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Magnitude of the disease burden from neurocysticercosis in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Distribution and density of cysticerci of Taenia solium by muscle groups and organs in naturally infected local finished pigs in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Treatment of cysticercosis with praziquantel in Colombia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A rapid immunoblot assay (western blot) to detect specific antibodies for human immunodeficiency virus, Schistosoma mansoni, and Taenia solium (Cysticercosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The seroprevalence of Taenia solium cysticercosis among epileptic patients in León, Nicaragua, as evaluated by ELISA and western blotting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Methods for assessing the burden of parasitic zoonoses: echinococcosis and cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Estimation of the cost of Taenia solium cysticercosis in Eastern Cape Province, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis and epilepsy: a critical review.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

An epidemiological study of Taenia solium cysticercosis in a rural population in the Bolivian Chaco.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Detection of antigens of larval Taenia solium in the cerebrospinal fluid of patients with the use of HPLC and ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Single-day praziquantel therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Headache and cysticercosis in Ecuador, South America.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epilepsy and neurocysticercosis in an Andean community.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium cysticercosis in young pigs: age at first infection and histological characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Albendazole treatment in human taeniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Proposed diagnostic criteria for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Rising consumption of meat and milk in developing countries has created a new food revolution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The global campaign against epilepsy in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Immunodiagnostic tools for human and porcine cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The control of human (neuro)cysticercosis: which way forward?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium cysticercosis in a village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Albendazole therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

High prevalence of calcified silent neurocysticercosis in a rural village of Mexico.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

New concepts in the diagnosis and management of neurocysticercosis (Taenia solium).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Current consensus guidelines for treatment of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Human and porcine Taenia solium infection in a village in the highlands of Cusco, Peru. The Cysticercosis Working Group in Peru.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Treatment of porcine cysticercosis with oxfendazole: a dose-response trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Time-response curve of oxfendazole in the treatment of swine cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Effective, single-dose treatment or porcine cysticercosis with oxfendazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Control of Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Protection of pigs with cysticercosis from further infections after treatment with oxfendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Differential diagnosis of Taenia saginata and Taenia solium infections: from DNA probes to polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Persistence of passively transferred antibodies in porcine Taenia solium cysticercosiss

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Payer costs of patients diagnosed with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

High prevalence of serological markers of cysticercosis among epileptic Malagasy children

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia saginata (Cestoda) in western Kenya: the reliability of faecal examinations in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis: imported and autochthonous infections in Kuwait

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Vaccination against Taenia solium cysticercosis in underfed rustic pigs of México: roles of age, genetic background and antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Immunodiagnostic and molecular approaches for the detection of taeniid cestode infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Human Taeniasis and cysticercosis in Asia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

ELISA and immunoblot using purified glycoproteins for serodiagnosis of cysticercosis in pigs naturally infected with Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Dogs as alternative intermediate hosts of Taenia solium in Papua (Irian Jaya), Indonesia confirmed by highly specific ELISA and immunoblot using native and recombinant antigens and mitochondrial DNA analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis/taeniasis in Asia and the Pacific

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Application of the enzyme-linked immunoelectrotransfer blot to filter paper blood spots to estimate seroprevalence of cysticercosis in Bolivia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Species identification after treatment for human taeniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Improving meat inspection and control in resource-poor communities: the Nepal example

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Evaluation of the efficacy of albendazole against the larvae of Taenia solium in experimentally infected pigs, and kinetics of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cost of epilepsy in patients attending a secondary-level hospital in India

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Improving pig husbandry in tropical resource-poor communities and its potential to reduce risk of porcine cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis in Peace Corps volunteers in Madagascar

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Vaccines for prevention of cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Eradication of Taenia solium cysticercosis: a role for vaccination of pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The current status of neurocysticercosis in Eastern and Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Tapeworms and seizures--treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A phylogenetic hypothesis for the distribution of two genotypes of the pig tapeworm Taenia solium worldwide.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Calcific neurocysticercosis and epileptogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Recent advances in the diagnosis and treatment of cerebral cysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Edema associated with calcified lesions in neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Calcified cysticerci provoke perilesional edema and seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

A seroepidemiological study of human cysticercosis in West Cameroon.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia saginata: polymerase chain reaction for taeniasis diagnosis in human fecal samples

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Control of Taenia solium taeniasis/cysticercosis: from research towards implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Chemotherapy of porcine cysticercosis with albendazole sulphoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The prevalence of porcine cysticercosis in Eastern and Southern provinces of Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiological survey of swine cysticercosis in two rural communities of West-Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiology and aetiology of epilepsy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Antiepileptic therapies in the Mifi Province in Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Management of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Economic losses caused by foodborne parasitic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium metacestode viability in infected pork after preparation with salt pickling or cooking methods common in Yucatán, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiological study of Taenia solium taeniasis/cysticercosis in a rural village in Yucatan state, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Comparison of conventional techniques to differentiate between Taenia solium and Taenia saginata and an improved polymerase chain reaction-restriction fragment length polymorphism assay using a mitochondrial 12S rDNA fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis among children in Chicago

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Parasites in fine needle breast aspirates--assessment of host tissue response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Seroprevalence of Taenia solium cysticercosis in pigs in a rural community of Honduras.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiological study of Taenia solium infections in a rural village in Honduras

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Prevalence of taeniasis and cysticercosis in a population of urban residence in Honduras.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Evaluation of tongue inspection and serology for diagnosis of Taenia solium cysticercosis in swine: usefulness of ELISA using purified glycoproteins and recombinant antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis in an Orthodox Jewish community in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Limitations of current diagnostic procedures for the diagnosis of Taenia solium cysticercosis in rural pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Sero-epidemiological studies of cysticercosis in school children from two rural areas of Transkei, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Porcine cysticercosis in village pigs of North-West Cameroon.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis-related deaths, California

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Therapy of parenchymal brain cysticercosis with praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium infection in Irian Jaya (west Papua), Indonesia: a pilot serological survey of human and porcine cysticercosis in Jayawijaya district

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Economic burden of epilepsy in India.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Seizures and praziquantel. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis in Oregon, 1995-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/IgG activities to Taenia solium antigens in experimental infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Taenia solium Cysticercosis, Irian Jaya, Indonesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

DNA differential diagnosis of taeniasis and cysticercosis by multiplex PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

DNA differential diagnosis of human taeniid cestodes by base excision sequence scanning thymine-base reader analysis with mitochondrial genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Cysticercosis: Recent Advances in Diagnosis and Management of Neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

The relationship of antibody levels to the clinical spectrum of human neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Oxfendazole treatment of sheep with naturally acquired hydatid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Cysticercosis Working Group in Peru (CWG).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Treatment of porcine cysticercosis with albendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan state, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Hygiene and restraint of pigs is associated with absence of Taenia solium cysticercosis in a rural community of Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

Parasitic diseases: opportunities and challenges in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2805%2961012-3

7 January 2021

10.1016/S0065-308X(05)61012-3

Identifiers

DOI

1 reference

release_3w7hhp27effmzcxg5pqau7ofjy

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3w7hhp27effmzcxg5pqau7ofjy

24 November 2022

mapped directly with Wikidata item

PubMed ID

16735172

1 reference

PubMed ID

16735172